CSIMarket
 


Allakos Inc   (ALLK)
Other Ticker:  
 
 

ALLK's Operating Income Growth by Quarter and Year

Allakos Inc 's Operating Income results by quarter and year




ALLK Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -46.22 -96.08 -42.44
III Quarter September -48.21 -31.45 -62.62 -40.40
II Quarter June -37.82 -49.12 -57.20 -29.87
I Quarter March -45.05 -195.65 -55.59 -26.85
FY   -131.08 -322.44 -271.49 -139.56



ALLK Operating Income third quarter 2023 Y/Y Growth Comment
Allakos Inc in the third quarter 2023 recorded Operating Loss of $ -48.21 millions.

According to the results reported in the third quarter 2023, Allakos Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Allakos Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2023.

Explain Operating Income growth


ALLK Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Allakos Inc 's third quarter 2023 Operating Income $ -48.21 millions ALLK's Income Statement
Allakos Inc 's third quarter 2022 Operating Income $ -31.45 millions Quarterly ALLK's Income Statement
New: More ALLK's historic Operating Income Growth >>


ALLK Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Allakos Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ALLK's III. Quarter Q/Q Operating Income Comment
Recent accomplishment of -48.21 millions by Allakos Inc come out even less good considering the Operating Loss -37.82 millions a quarter before.

Within Major Pharmaceutical Preparations industry Allakos Inc achieved highest sequential Operating Income growth. While Allakos Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ALLK's III. Quarter Q/Q Operating Income Comment
III. Quarter 2023 accomplishment of -48.21 millions by Allakos Inc look even less good if you take a look at -37.82 millions a quarter before.

Within Major Pharmaceutical Preparations industry Allakos Inc achieved highest sequential Operating Income growth. While Allakos Inc 's Operating Income growth quarter on quarter, overall rank is .


Allakos Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Operating Income 12 Months Ending $ -177.29 $ -160.52 $ -171.82 $ -322.43 $ -372.29
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Allakos Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Allakos Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
ALLK's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for ALLK's Competitors
Operating Income Growth for Allakos Inc 's Suppliers
Operating Income Growth for ALLK's Customers

You may also want to know
ALLK's Annual Growth Rates ALLK's Profitability Ratios ALLK's Asset Turnover Ratio ALLK's Dividend Growth
ALLK's Roe ALLK's Valuation Ratios ALLK's Financial Strength Ratios ALLK's Dividend Payout Ratio
ALLK's Roa ALLK's Inventory Turnover Ratio ALLK's Growth Rates ALLK's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2023
Pro dex Inc 92.95%$ 92.947 millions
Merit Medical Systems Inc88.33%$ 88.331 millions
Infusystem Holdings Inc79.96%$ 79.958 millions
Elite Pharmaceuticals Inc 78.10%$ 78.103 millions
Amneal Pharmaceuticals Inc 70.56%$ 70.559 millions
Fonar Corporation68.01%$ 68.013 millions
Integer Holdings Corporation64.31%$ 64.314 millions
Cadre Holdings inc 62.18%$ 62.183 millions
Progyny Inc 61.61%$ 61.608 millions
Neurocrine Biosciences Inc 60.82%$ 60.820 millions
Davita Inc 59.06%$ 59.063 millions
Incyte Corporation55.16%$ 55.161 millions
Cardiff Lexington Corporation51.41%$ 51.406 millions
Lemaitre Vascular Inc 49.27%$ 49.268 millions
Msa Safety Incorporated46.35%$ 46.351 millions
Merck and Co Inc 43.22%$ 43.220 millions
Iradimed Corporation42.91%$ 42.907 millions
Select Medical Holdings Corp42.08%$ 42.084 millions
Semler Scientific inc 41.01%$ 41.012 millions
Dexcom Inc 39.32%$ 39.322 millions
Ir med Inc 36.64%$ 36.644 millions
Option Care Health Inc 33.48%$ 33.481 millions
Lftd Partners Inc 33.17%$ 33.168 millions
Lantheus Holdings Inc 31.04%$ 31.044 millions
Addus Homecare Corporation30.39%$ 30.389 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com